What is Response Pharmaceuticals worth?
$30.0Mlast known valuation
Response Pharmaceuticals last raised $3.9M in its Debt (Jun 2024).
Free account
See the evidence behind this price
- ·Post-money valuations for all 2 rounds
- ·The complete investor list — 6 names
- ·Watchlist + deal alerts for Response Pharmaceuticals
Create free account
No card required
Funding history
2 rounds| Date | Round | Raised | Post-money | $/share |
|---|---|---|---|---|
| Jun 2024 | Debt | $3.9M | ▮ | ▮ |
| Feb 2022 | Early Stage VC | $8.0M | ▮ | ▮ |
How Response Pharmaceuticals's valuation is determined
Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.
For Response Pharmaceuticals, too few pricing signals exist to publish a composite mark; the figures above reflect the most recent observed valuation event. Full methodology →
Frequently asked
- What is Response Pharmaceuticals worth?
- Response Pharmaceuticals's last known valuation is $30.0M.
- How much has Response Pharmaceuticals raised?
- Response Pharmaceuticals has raised $16.9M in total funding across 2 recorded rounds.
- When did Response Pharmaceuticals last raise?
- Response Pharmaceuticals last raised in Jun 2024 (Debt), raising $3.9M.